Showing results (91-100 of 223) with videos related to
Sort By:
Pageof 23
Transfusion|February 18, 2009
Investigation of whether the acute hemolysis associated with Rh(o)(D) immune globulin intravenous (human) administration for treatment of immune thrombocytopenic purpura is consistent with the acute hemolytic transfusion reaction modelAnn Reed Gaines, Hallie Lee-Stroka, Karen Byrne, et al.Blood|July 16, 2009
Plerixafor (AMD3100) and granulocyte colony-stimulating factor (G-CSF) mobilize different CD34+ cell populations based on global gene and microRNA expression signaturesRobert E Donahue, Ping Jin, Aylin C Bonifacino, et al.Journal of Translational Medicine|March 16, 2018
Comparison of human bone marrow stromal cells cultured in human platelet growth factors and fetal bovine serumJiaqiang Ren, Dawn Ward, Steven Chen, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 17, 2012
Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatmentJianjian Jin, Marianna Sabatino, Robert Somerville, et al.Transfusion|May 29, 2019
How do I structure logistic processes in preparation for outsourcing of cellular therapy manufacturing?Leonard N Chen, Naoza Collins-Johnson, Nasheda Sapp, et al.Expert Opinion on Biological Therapy|February 26, 2008
Spontaneous and treatment-induced cancer rejection in humansEna Wang, Silvia Selleri, Marianna Sabatino, et al.Transfusion|April 6, 2006
Streptococcus agalactiae sepsis after transfusion of a plateletpheresis concentrate: benefit of donor evaluationWesley T Stevens, Charles D Bolan, Jaime M Oblitas, et al.Tissue Engineering. Part B, Reviews|December 26, 2013
Establishing a bone marrow stromal cell transplant program at the National Institutes of Health Clinical CenterDavid F Stroncek, Marianna Sabatino, Jiaqiang Ren, et al.Transfusion|October 26, 2007
Pasteurella multocida bacteremia in asymptomatic plateletpheresis donors: a tale of two catsBarbara J Bryant, Cathy Conry-Cantilena, Alice Ahlgren, et al.Cytotherapy|September 3, 2013
Simplified process for the production of anti-CD19-CAR-engineered T cellsBarbara Tumaini, Daniel W Lee, Tasha Lin, et al.Pageof 23